Oxidative Medicine and Cellular Longevity
Volume 2016 (2016), Article ID 1340903, 10 pages
http://dx.doi.org/10.1155/2016/1340903

Research Article

The Influence of Probiotic Lactobacillus casei in Combination with Prebiotic Inulin on the Antioxidant Capacity of Human Plasma

Paulina Kleniewska, Arkadiusz Hoffmann, Ewa Pniewska, and Rafał Pawliczak

Department of Immunopathology, Faculty of Biomedical Sciences and Postgraduate Training, Medical University of Lodz, Ulica Zeligowskiego 7/9, 90-752 Lodz, Poland

Received 14 September 2015; Revised 5 February 2016; Accepted 11 February 2016

Academic Editor: Vasantha Rupasinghe

Copyright © 2016 Paulina Kleniewska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

The aim of the present study was to assess whether probiotic bacteria Lactobacillus casei (4 × 10⁸ CFU) influences the antioxidant properties of human plasma when combined with prebiotic Inulin (400 mg). Experiments were carried out on healthy volunteers (). Volunteers were divided according to sex (16 male and 16 female) and randomly assigned to synbiotic and control groups. Blood samples were collected before synbiotic supplementation and after 7 weeks, at the end of the study. Catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx) activity, and the ferric reducing ability of plasma (FRAP) in human plasma were examined. The administration of synbiotics containing L. casei plus Inulin resulted in a significant increase in FRAP values () and CAT activity () and an insignificant increase in SOD and GPx activity compared to controls. Synbiotics containing L. casei (4 × 10⁸ CFU) with prebiotic Inulin (400 mg) may have a positive influence on human plasma antioxidant capacity and the activity of selected antioxidant enzymes.

1. Introduction

Reactive oxygen species (ROS) are reactive chemical individuals incorporating oxygen atoms with an unpaired electron (radical) or O-O bond and are capable of participating in chemical reactions [1]. ROS play a crucial role in the basic biological processes in the body. These molecules participate in oxidation and reduction reactions (in the respiratory chain) and the removal of toxins, renew energy (ATP), and enable oxygen transport by hemoglobin, activation of cytochrome P450, and the phagocytosis of microorganisms. However, their overproduction can lead to free radical reactions, resulting in damage to lipids, proteins, carbohydrates, and nucleic acids. The quick and easy diffusion of ROS and their ability to react with multiple nonspecific components cells may lead to disturbances of many biological processes, which may result in the development of a number of diseases.

There are two types of ROS sources: endogenous and exogenous. Endogenous sources comprise those generated intracellularly and acting within the cell, and these include free radicals formed within the cell and then released into the surrounding area. Exogenous sources of ROS include a large number of chemical pollutants, medications, principally cancer chemotherapeutics, environmental agents (like nongenotoxic carcinogens), various xenobiotics, particularly chlorinated ones, metal ions, tobacco smoke, barbiturates, or radiation [2, 3]. ROS can also be divided into oxygen-centered nonradicals (singlet oxygen, ¹O₂; hydrogen peroxide, H₂O₂; ozon, O₃) and oxygen-centered radicals (hydroxyl radical, •OH; superoxide anion, ; or hydroperoxyl, ) [4].

Fortunately, the human organism has developed a number of enzymatic and nonenzymatic defense mechanisms against the harmful effects of ROS. Antioxidant enzymes, such as superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), play an important role in the prevention of free radical damage in living organisms. Their mechanism of action creates an integrated system of antioxidant protection [5].

The biological role of SOD catalyzes the reaction of dismutation. The enzyme is found in three forms: copper-zinc SOD (Cu/ZnSOD, SOD1), manganese SOD (MnSOD, SOD2), and extracellular superoxide dismutase (EC-SOD, SOD3) [6]. SOD1 is present in the cytosol and in the mitochondrial intermembrane space [7, 8]. SOD2 is localized in all mammalian cells but mainly in the mitochondrion and peroxisomes. The dismutation of by MnSOD is similar to the reaction conducted by SOD1 and consists of two stages. MnSOD activity can be induced by a number of factors, including interleukin-1, liposaccharides (LPS), and TNF-α, and its increased activity protects cells against oxidative stress [6, 9]. SOD3 is present in plasma, tissues, and extracellular fluids such as synovial fluid and lymph.

Another important antioxidant enzyme which closely interacts with SOD is CAT. This enzyme decomposes H₂O₂ to O₂ and H₂O and is present in most organisms exposed to O₂. CAT acts as both a catalase and a peroxidase. While its basic function is catalytic, in the presence of low H₂O₂ concentrations, it can also oxidize low molecular weight alcohols such as methanol or ethanol to aldehydes and water [10, 11]. CAT activity depends on substrate concentration, pH, temperature, inhibitors, or activators. The absence of CAT in the blood and other tissues in the human body leads to the occurrence of acatalasia, which is manifested by recurrent inflammation of the gums and ulcers in the mouth, or hypocatalasia. Reduced CAT activity is visible in a number of diseases accompanied by oxidative stress and inflammation, including atherosclerosis, pneumonia, tuberculosis, hepatitis, type 2 diabetes, cancer, or neurodegenerative diseases [12].

The main function of GPx is to reduce H₂O₂ and organic peroxides with the involvement of reduced glutathione (GSH). This enzyme is capable of restoring GSH using NADPH. Human GPx has several isozymes and each of them is encoded by a different gene. GPx isozymes are characterized by various features including structure, function, reactivity, substrate specificity, or location. GPx exists in eight isoforms, the most important of which are cytosolic (GPx-1, cGPx), gastrointestinal (GPx-2, giGPx), plasma (GPx-3, pGPx), and the phospholipid hydroperoxides peroxidase (GPx-4, phGPx) located in the cytoplasm and mitochondria. The products of lipid peroxidation (LO) may have an effect on GPx, one particular example being 4-hydroxynonenal (4-HNE), which reduces the amount of GSHt and inactivates cGPx by reaction with -SH group [13].

The World Health Organization regards probiotics as living microorganisms which have beneficial health effects if they are administered in appropriate amounts. Gibson and Roberfroid [14] define prebiotics as “nondigestible food ingredients that beneficially affect the host by selectively stimulating the growth and/or activity of one or a limited number of bacteria in the colon.” Finally, the term “synbiotic” is used when a product contains both probiotics and prebiotics.

In recent years, the number of studies, both in vitro and in vivo, related to the antioxidant properties of probiotics has significantly increased [15, 16]. The aim of the present study was to assess whether the probiotic bacteria L. casei influences the antioxidant properties of human plasma when administered in combination with prebiotic Inulin.

2. Materials and Methods

2.1. Experimental Design

This randomized study was carried out at the Medical University of Lodz (Poland) from December 2014 to February 2015. The total number of healthy volunteers (aged 20–35) was first divided into groups of men () and women (). The subjects were then randomly assigned to synbiotic and control groups. Only subjects who had given voluntary informed consent were included in the study. The exclusion criteria included medical conditions requiring drug therapy, administration of nonsteroidal or anti-inflammatory drugs, use of any antimicrobial agent within the previous month, history of gastrointestinal diseases, acute infections, or food allergy. Also, athletes, subjects who were consuming yogurts at the time, subjects who were on special diets which might affect the antioxidant properties of plasma, or subject who were taking antioxidant vitamins were excluded. Blood samples were collected from the forearm veins before synbiotic supplementation and after seven weeks, at the end of the study.

The experimental procedures were approved by the Ethical Committee of the Medical University of Lodz (number RNN/801/14/KB).

2.2. Tested Dietary Supplement

A synbiotic supplement containing Lactobacillus casei with Inulin was purchased from ICN Polfa Rzeszow S.A., Poland. Each capsule contained 4 × 10⁸ CFU lyophilized Lactobacillus casei and 400 mg of Inulin. One capsule of synbiotic per day was administered to subjects, at dinner time for 7 weeks. The control group did not consume any synbiotics during the time of the study.

2.3. Preparation of Samples

Blood was collected into two tubes containing appropriate anticoagulant (EDTA or heparin). Blood samples were drawn from forearm veins into Vacuette tubes with EDTA as an anticoagulant for the CAT, SOD, and GPx assays or heparin as an anticoagulant for the FRAP assay. The blood was centrifuged at 1000 ×g for 10 minutes at 4°C or at 3000 ×g for 10–15 minutes at 4°C (Hettich Universal 320R Centrifuge). The obtained plasma was collected into Eppendorf tubes, frozen (−80°C), and stored for further examinations. Unfrozen, previously prepared plasma was used for measurement of antioxidant enzymes and FRAP.

2.4. Measurement of Plasma Antioxidant Capacity by FRAP Method

To determine the reducing ability of plasma, the FRAP method was used [17]. FRAP is a method to evaluate enzymatic and nonenzymatic plasma antioxidants such as low molecular weight peptides like bilirubin, C and E vitamins, uric acid, and albumins. The test works on the principle that the antioxidants contained in a sample reduce ferric-tripyridyltriazine Fe³⁺-TPTZ to the ferrous form Fe²⁺-TPTZ, which absorbs light at 593 nm.

Chemicals. The following chemicals were used: acetate buffer (300 mM; pH = 3,6); TPTZ (2,3,5-triphenyltetrazolium chloride; 10 mM); hydrochloric acid (40 mM); ferric chloride (20 mM). All reagents were purchased from Sigma-Aldrich (Ulica Szelagowska 30, 61-626), Poland.

Assay Protocol. The reaction solution was prepared by mixing 10 volumes of 300 mM acetate buffer, pH 3.6 with 1 volume of 10 mM TPTZ in 40 mM HCl and 1 volume of 20 mM FeCl₃·6H₂O. Following this, 30 μL of human plasma and 90 μL of deionized water were added to 900 μL of the FRAP reagent. Absorbance was measured at 593 nm with a spectrophotometer (Perkin-Elmer Lambda 25).

2.5. Measurement of CAT Activity in Human Plasma

To measure CAT activity, a Catalase Assay Kit (Item number 707002), manufactured by Cayman Chemical Company, Ann Arbor, MI (BIOKOM, Ulica Wspolna 3, 05-090 Janki, Poland), was used. This method is based on the reaction of an enzyme with methanol in the presence of optimal H₂O₂ concentration. The produced formaldehyde is measured colorimetrically with 4-amino-3-hydrazino-5-mercapto-1,2,4-triazole (Purpald) as chromogen. Purpald specifically forms a bicyclic heterocycle with aldehydes, which, upon oxidation, changes from colorless to purple [18].

Chemicals. Catalase Assay Kit, Item number 707002, consisted of Catalase Assay Buffer (2 mL of Catalase Assay Buffer diluted with 18 mL of HPLC-grade water), Catalase Sample Buffer (5 mL of Catalase Sample Buffer diluted with 45 mL of HPLC-grade water), catalase formaldehyde standard (4,25 M formaldehyde); Catalase-Control (powder was dissolved in 2 mL of final Sample Buffer; subsequently, 100 μL of reconstituted enzyme was diluted with 1.9 mL of final Sample Buffer), catalase potassium hydroxide (4 mL of 10 M potassium hydroxide), Catalase Hydrogen Peroxide (40 μL of 8.82 M Catalase Hydrogen Peroxide was diluted with 9.96 mL of HPLC-grade water), Catalase Purpald (4 mL of 4-amino-3-hydrazino-5-mercapto-1,2,4-triazole in 0.5 M hydrochloric acid), catalase potassium periodate (1.5 mL of potassium periodate in 0.5 M potassium hydroxide), methanol, and HPLC-grade water.

Assay Protocol. After preparation of CAT Standard wells, each well on the plate was filled with 100 μL of diluted Assay Buffer, 30 μL of methanol, and 20 μL of sample (plasma). Following this, 20 μL of hydrogen peroxide was added to all used wells, and the plate was covered and incubated on a shaker for 20 minutes at room temperature (Thermo Scientific MaxQ 4000). To terminate the reaction, 30 μL of potassium hydroxide was added. After a 10-minute incubation on the shaker with Catalase Purpald (30 μL per well), the solution was finally incubated with potassium periodate (5 minutes, 10 μL per well). Absorbance was read at 540 nm.

2.6. Measurement of SOD Activity in Human Plasma

To measure SOD activity, a Superoxide Dismutase Assay Kit (Item number 706002), manufactured by Cayman Chemical Company, Ann Arbor, MI (BIOKOM, Ulica Wspolna 3, 05-090 Janki, Poland), was used. This method uses tetrazolium salt for detection of superoxide radicals generated by hypoxanthine and Xanthine Oxidase. This assay measures all three types of SOD [19].

Chemicals. The Superoxide Dismutase Assay Kit (Item number 706002) consisted of the following: Assay Buffer (3 mL of Assay Buffer diluted with 27 mL of HPLC-grade water), Sample Buffer (2 mL of Sample Buffer diluted with 18 mL of HPLC-grade water), Radical Detector (50 μL of Radical Detector diluted with 19.05 mL of diluted Assay Buffer), SOD Standard (100 μL of bovine erythrocyte SOD), Xanthine Oxidase (50 μL of Xanthine Oxidase diluted with 1.95 mL of diluted Assay Buffer), and HPLC-grade water.

Assay Protocol. After preparation of SOD Standard wells, each well on the plate was filled with 200 μL of diluted Radical Detector and 10 μL of sample (plasma). To initiate the reaction, 20 μL of diluted Xanthine Oxidase was added to all used wells; the plate was mixed for a few seconds, covered, and incubated on a shaker for 30 minutes at room temperature (Thermo Scientific MaxQ 4000). Absorbance was read at 440–460 nm with a plate reader (Tecan Sunrise with software Magellan Standard).

2.7. Measurement of GPx Activity in Human Plasma

To measure GPx activity, the Glutathione Peroxidase Assay Kit (Item number 703102), manufactured by Cayman Chemical Company, Ann Arbor, MI (BIOKOM, Ulica Wspolna 3, 05-090 Janki, Poland), was used. In this method, GPx activity is indirectly measured by a coupled reaction with GR. GSSG, produced upon reduction of H₂O₂ by GPx, becomes recycled to its reduced state by GR and NADPH. Oxidation of NADPH to NADP+ is related with decrease in absorbance at 340 nm [20].

Chemicals. Glutathione Peroxidase Assay Kit Item number 703102 consisted of GPx Assay Buffer (3 mL of GPx Assay Buffer was diluted with 27 mL of HPLC-grade water), GPx Sample Buffer (2 mL of Sample Buffer was diluted with 18 mL of HPLC-grade water), glutathione peroxidase-Control (10 μL of glutathione peroxidase was diluted with 490 μL of final Sample Buffer), GPx Cosubstrate Mixture (each vial was reconstituted with 6 mL of HPLC-grade water and mixed), and GPx Cumene Hydroperoxide.

Assay Protocol. After preparation of the background wells and positive control wells, the sample wells were prepared: 100 μL of final Assay Buffer, 50 μL of GPx Cosubstrate Mixture, and 20 μL of sample (plasma) were added. To initiate the reaction, 20 μL of GPx Cumene Hydroperoxide was added to all used wells and the plate was carefully mixed for a few seconds. Absorbance was read every minute at 340 nm with a plate reader to obtain readings at five time points.

2.8. Statistical Analysis

All results were expressed as mean ± standard error of the mean (SEM). Groups were compared using the Student’s -test and Mann-Whitney rank sum test. The selection of appropriate tests depended on the distribution of the obtained data. values lower than 0.05 were considered statistically significant.

3. Results

3.1. Evaluation of FRAP Values

The FRAP assay revealed a nonsignificant increase from  μmol/L to  μmol/L () in the control group but a significant increase from  μmol/L to  μmol/L () in the synbiotic group. In the female-control group, antioxidant capacity increased insignificantly from  μmol/L to  μmol/L (), while, in the female-synbiotic group, plasma antioxidant capacity rose significantly from  μmol/L to  μmol/L after synbiotic administration (). In the male-control group, antioxidant capacity increased insignificantly from μmol/L to  μmol/L (), while, in the male-synbiotic group, plasma antioxidant capacity rose significantly from  μmol/L to  μmol/L following synbiotic administration () (Figure 1).

Figure 1: The influence of combination of probiotic Lactobacillus casei (4 × 10⁸ CFU) and prebiotic Inulin (400 mg) on the FRAP values. Data is shown as mean ± SEM. ; ; versus control group.

3.2. Evaluation of CAT Activity

CAT activity was found to increase insignificantly from  nmol/min/mL to  nmol/min/mL in the control group. However, CAT activity showed a significant () increase from  nmol/min/mL to  nmol/min/mL over the course of the experiment in the synbiotic group. In the female-control group, CAT activity decreased from  nmol/min/mL to  nmol/min/mL. In contrast, CAT activity was significantly higher in the female-synbiotic group and increased from  nmol/min/mL to  nmol/min/mL over the seven weeks of the study (). In the male-control group, CAT activity decreased from  nmol/min/mL to  nmol/min/mL. In the male-synbiotic group, the initial value of CAT activity was  nmol/min/mL. After synbiotic administration, CAT activity increased insignificantly to  nmol/min/mL () (Figure 2).

Figure 2: The influence of combination of probiotic Lactobacillus casei (4 × 10⁸ CFU) and prebiotic Inulin (400 mg) on the CAT activity. Data is shown as mean ± SEM. ; versus control group.

3.3. Evaluation of SOD Activity

In the control group, SOD activity demonstrated a nonsignificant increase from  U/mL to  U/mL (). In the synbiotic group, SOD activity showed a nonsignificant increase from to  U/mL (). In the female-control group, SOD activity increased, but not significantly (), from  U/mL to  U/mL. In the female-synbiotic group, an insignificant rise in SOD activity was observed from  U/mL to  U/mL following synbiotic administration (). In the male-control group, SOD activity decreased from  U/mL to  U/mL. In the male-synbiotic group, SOD activity also rose insignificantly from  U/mL to  U/mL following synbiotic administration () (Figure 3).

Figure 3: The influence of combination of probiotic Lactobacillus casei (4 × 10⁸ CFU) and prebiotic Inulin (400 mg) on the SOD activity. Data is shown as mean ± SEM.

3.4. Evaluation of GPx Activity

A nonsignificant increase in GPx activity was observed in the control group from  nmol/min/mL to  nmol/min/mL (), while a nonsignificant increase was observed in the synbiotic group from  nmol/min/mL to  nmol/min/mL (). The level of GPx activity increased also in the female-synbiotic and male-synbiotic groups. However, no significant changes were observed.

4. Discussion

The present work was carried out on healthy volunteers randomly divided into groups of men and women, which were then subdivided into synbiotic and control groups. The study was not blinded because the control group did not consume any supplements during this time. Similar results, that is, that probiotic supplementation led to an increase in plasma antioxidant levels, were reported by Martarelli et al. [21] in a study of healthy athletes during intense exercise training.

This paper shows that administration of synbiotics containing Lactobacillus casei with Inulin caused a significant increase in the FRAP values of human plasma. FRAP is a sensitive indicator of the total antioxidant status of biological fluid. Many authors [22–27] have reported that probiotics have antioxidant properties, with or without prebiotics. These works indicate that a limited number of probiotic strains may lessen oxidative stress by several mechanisms. Firstly, direct neutralization of oxidants in the intestinal tract is possible by the expression of antioxidant enzymes (e.g., SOD, CAT, and GPx). In addition, stimulation of the immune system can reduce inflammation and prevent cytokine-induced oxidative stress. Another route is by the inhibition of intestinal pathogens, which reduces inflammation and associated oxidative damage. Probiotics may also enhance the absorption of micro- and macronutrients, including antioxidants, or finally reduce postprandial lipids, which are connected with oxidative damage and are often responsible for some food-related pathologies [21, 25].

As mentioned above, Martarelli et al. [21] report that probiotic supplementation (Lactobacillus paracasei IMC 502 and Lactobacillus rhamnosus IMC 501) led to an increase in plasma antioxidant levels in a group of athletes during four-week intense physical activity. The antioxidant properties of probiotics in human volunteers have been confirmed elsewhere [26]. The antioxidative potential of L. fermentum ME-3, examined by blood total antioxidative activity (TAA) and total antioxidative status (TAS), was found to be much higher in the study group than an accompanying placebo group. Probiotics were also examined in vitro to investigate their antioxidant properties. This experiment provided an opportunity for a very extensive analysis, which included a range of parameters and a number of bacterial strains.

Amaretti et al. [28] examined several parameters, including ascorbate autoxidation () and SOD activity, to determine the antioxidant properties of 34 strains of lactic acid bacteria: 7 species of the Bifidobacterium genus, 6 of Lactococcus, 10 of S. thermophilus, and 11 of Lactobacillus. This analysis revealed that the level and particular mechanisms of antioxidant activity are specific for bacterial strain: Lactococcus strains were characterized by the highest SOD activity, while Lactobacillus spp. and S. thermophilus showed highest . The probiotic strains administered together (DOXO-induced oxidative stress in the animal model) increased the plasma total antioxidant activity of probiotic group. Similarly, Hathout et al. [29] have reported that administration of Lactobacillus casei and Lactobacillus reuteri increased total antioxidant capacity (TAC) in supplemented rats.

Recently, Gagnon et al. [30] evaluated the bioaccessibility of antioxidants in milk fermented by selected B. longum subsp. longum strains during in vitro dynamic digestion. All strains appeared to have some antioxidant properties evaluated by Oxygen Radical Absorbance Capacity (ORAC) Assay.

Our results show that administration of synbiotics resulted in a significant increase in the CAT activity of human plasma. These findings are consistent with recent studies. Shen et al. [31] demonstrate that CAT activity significantly increases in serum after administration of B. animalis 01 ICFE. Chamari et al. [32] report a significant increase in CAT activity in a group of healthy female subjects receiving probiotic supplementation compared to controls. Similarly, Shen et al. [33] demonstrate that L. plantarum administration increased CAT activity in liver chickens. Other studies have also shown that probiotics can enhance the activity of CAT in different tissues [34, 35].

Our results indicate that the CAT level was two times higher in women than in men after synbiotic administration. Some studies note that, apart from genetic factors, catalase activities are influenced by a number of environmental factors, for example, seasonal variations [36, 37]. In addition, melatonin can regulate its activity. Its concentration during the day is higher in autumn and winter [38]. Ito et al. [39] suggest that daytime melatonin levels are higher in females with psychological stress derived from living environment, lifestyle habits, or premenstrual syndrome. This observed gender variation in CAT activity could be explained by different levels of hormones, such as testosterone and oestradiol. Testosterone has prooxidant properties while oestradiol acts as an antioxidant. Schröder et al. [40] also confirmed that estrogens have in vitro and in vivo antioxidant effects.

Some studies have confirmed that sports have an effect on catalase activity. Balog et al. [36] found women to have higher CAT activity than men. However, while sports had no effect on the group of women, sports decreased CAT activity in the autumn in the group of men. It was also observed that the inflammatory diseases are preceded by increased catalase activity in plasma [41–43].

Although our study found that synbiotic administration caused an insignificant increase in SOD activity in human plasma, other authors report a statistically significant increase in activity. These differences can be accounted for by the use of different bacterial strains, doses, and timing of administration. Moreover, in the present study, the subjects were administrated probiotic with prebiotic Inulin and no placebo group was used. Gao et al. [44] note that Lactobacillus plantarum FC225 (isolated from fermented cabbages) therapy could significantly elevate the activity of SOD. Wang et al. [45] report that, after application of L. fermentum to pigs, the activity of SOD significantly increased in serum. Ejtahed et al. [46] discuss the influence of probiotic consumption on antioxidant status of blood in patients with type 2 diabetes. Probiotic yogurt significantly increased SOD activity in comparison to controls. Another study has also reported increases in SOD activity after synbiotic administration [31].

The present work shows that administration of synbiotics resulted in an insignificant increase in GPx activity in human plasma. However, other studies report significant increases in activity, but these used different strains of probiotics without Inulin. A recent study by Gan et al. [47] notes that selenium-enriched probiotics improve the antioxidant status of piglets and increase blood GPx activity. Pandey et al. [48] report that probiotic Escherichia coli CFR 16 ameliorates 1,2-dimethylhydrazine-induced oxidative damage in the colon and liver of rats, by pyrroloquinoline quinone (PQQ) production. The probiotic increased GPx activities to normal levels in the liver and colonic tissues of tested animals. Ghoneim and Moselhy [49] confirm that GPx activity was significantly higher in the tissues of animals fed with probiotics. GPx activity was elevated in the hepatic and muscular microsomes of animals treated with probiotic while it was insignificantly increased in the renal microsomes. Some other works confirm increased GPx activity after administration of probiotics [31, 33, 45, 46].

Furthermore, a significant increase in the activity of antioxidant enzymes (CAT, SOD, and GPx) was observed 90 days after application of Lactobacillus casei spp. but without Inulin [50]. However, some studies report decreased antioxidant enzyme activity in various tissues and blood after the application of probiotics. Fabian and Elmadfa [51] note that the mean activities of CAT and GPx decreased significantly in the plasma of healthy women after using probiotics. Vaghef-Mehrabany et al. [52] report insignificant differences in CAT activity and reduced GPx and SOD activity in the Lactobacillus casei 01 group. However, the key difference between our study and that of Vaghef-Mehrabany et al. is that their experiment was carried out only on patients with rheumatoid arthritis: an autoimmune inflammatory disease that causes great pain and disability and increasing oxidative stress. Other authors [53] note that lactic acid bacteria (LAB) show no significant antioxidant capacity. Chauhan et al. [54] report that administration of L. fermentum Lf1 did not result in any significant change with regard to catalase activity. Cecchi et al. [55] assert that antioxidant activity cannot be regarded as a feature of probiotics, as this characteristic is observed in microorganisms, even potentially pathogenic ones.

In this study, the administration of synbiotic resulted in higher activity of CAT, SOD, and GPx, which are important antioxidant enzymes in the human body. Additionally, FRAP assay of plasma found that total antioxidant capacity increased in the study group compared to the control group after administration of synbiotics. This may indicate that administration of synbiotics resulted in the development of antioxidant defense against the generation of reactive oxygen species.

Many authors describe correlations between probiotics and oxidative stress parameters. Ishii et al. [56] report that B. breve Yakult (BBY) oral administration attenuated UV-induced barrier perturbation and oxidative stress of the skin and attribute this antioxidative effect to the prevention of reactive oxygen species generation. Other studies [57, 58] have reported significant decreases in plasma MDA as an effect of bioactive peptides, which are released during fermentation by proteolytic LAB and which are responsible for the beneficial properties of fermented milk products.

Most of identified bioactive peptides were casein derived and they are able to inhibit both enzymatic lipid peroxidation and nonenzymatic lipid peroxidation and exhibit free radical scavenging properties [59]. Additionally, antioxidant peptides are probably related to cysteine-rich proteins that help with glutathione synthesis [60]. A previous study found that while two types of fermented yogurt exhibited some antioxidant activity, the probiotic yogurt was more effective than the conventional yogurt [46]. Several in vitro studies confirm the ability of LAB strains to inactivate ROS via enzymatic mechanisms based on a coupled NADH oxidase/peroxidase system. Lin and Chang [61] report that strains of B. longum and L. acidophilus manifest antioxidative activity and inhibit linoleic acid peroxidation, and this inhibition plays a role in the lipid peroxidation process. Many other works describe the beneficial influence of LAB on the reduction of oxidative damage [62, 63]. Yadav et al. [34] note that probiotics (Lactobacillus acidophilus NCDC14 and Lactobacillus casei NCDC19) significantly suppress STZ-induced oxidative damage in pancreatic tissues by inhibiting lipid peroxidation (LO) and preserving the antioxidant pool, for example, the activities of SOD, CAT, and GPx.

Recent reports [64, 65] have shown that S. boulardii is able to reduce drug induced oxidative damage, especially DNA damage within the pancreatic acinar cells of ANP-induced rats (acute necrotizing pancreatitis). Suryavanshi et al. [66] note that S. boulardii extract has the ability to significantly reduce ROS formation in an A549 cell model. The authors [67, 68] also report that homofermentative lactobacilli exhibit high antioxidant activity, while the antioxidant properties of heterofermentative lactobacilli are highly strain-dependent. The incorporation of green tea in a dose-dependent manner can increase the antiradical and ferric reducing ability of probiotics with both bioyogurts and acidophilus milk [69]. Grompone et al. [70] examined 78 strains of Lactobacillus and Bifidobacterium. Probiotic strains were administered to C. elegans; L. rhamnosus CNCM I-3690 demonstrated the highest antioxidant capacity. In another study [71] examining 13 strains of Lactobacillus spp., maximum antioxidant capacity, measured as oxidation inhibition, was observed in L. casei ssp. casei 19.

In addition to the production of antioxidants and free radical scavenging substances, probiotics exhibit some metal chelating activities. As transition metal ions can easily initiate LO or initiate the decomposition of hydroperoxides to peroxyl and alkyoxyl radicals, metal chelation influences the antioxidant properties of probiotics [72]. Lee et al. [73] confirmed that the antioxidant activity of L. casei KCTC 3260 is connected with the chelation of metal ions. Other studies report that the lactobacilli are able to prevent the production of OH• by the chelation of “free” ferrous ions, which initiate Fenton’s reaction [74], and the scavenging of Mn²⁺ [62]. The antioxidative effect of some probiotic strains is highlighted by the inhibition of ascorbate autoxidation, scavenging of free radicals, OH•, and metal ion chelation [46, 61, 75].

Although many authors discuss the antioxidant properties of probiotics, the mechanism of their action is not fully understood. Exopolysaccharides released by probiotic bacteria may potentially play a role in reducing oxidative stress. These long-chain polysaccharides consist of branched, repeating sugar units which protect probiotics under starvation conditions or extreme temperature and pH. Kodali and Sen [76] note that Bacillus coagulans RK-02 was able to perform extracellular biosynthesis of exopolysaccharides and found that EPS exhibited significant antioxidant activities in vitro, when compared to vitamin E and vitamin C. Şengül et al. [77] report lower levels of the oxidative biomarker myeloperoxidase (MPO) in a rat model treated with the low-EPS producing Lactobacillus strain A13 than a similar model treated with high-EPS producing Lactobacillus delbrueckii ssp. bulgaricus B3 following the induction of oxidative stress.

Moreover, Lactococcus lactis and Lactobacillus plantarum engineered to produce and release SOD demonstrated anti-inflammatory effects in the TNBS colitis model and gave significantly better results than infusion of bovine SOD [78]. Similarly, manganese SOD producing Lactobacillus gasseri demonstrated significant anti-inflammatory activity in IL-10-deficient mice [79]. Also, Kullisaar et al. and Chang and Hassan [80, 81] have reported that Streptococcus thermophilus and Lactobacillus fermentum strains show significant antioxidative activity thanks to production of SOD. Similarly, de Moreno de LeBlanc et al. [82] confirm that a CAT-producing L. lactis strain was able to prevent the occurrence of tumors in an experimental DMH-induced colon cancer model. Elsewhere [83], it was found that the cooperation between CAT and SOD could significantly enhance oxidative resistance in L. rhamnosus.

Some authors have described the implication of probiotic use in the prevention and treatment of various diseases. Some refer to the antioxidant hypothesis when discussing cardiovascular disease (CVD) prevention and treatment using Lactobacillus strains. Wang et al. [84] have proved that L. plantarum CAI6 and L. plantarum SC4 may protect against CVD by lipid metabolism regulation and Nrf2-induced antioxidative defense in hyperlipidemic mice. Lutgendorff et al. [85] report that probiotic pretreatment could successfully prevent acute pancreatitis- (AP-) induced GSH depletion, stimulate mucosal GSH biosynthesis compared with control and sham-operated rats, and prevent moderate AP-induced barrier dysfunction. van Minnen et al. [86] note that pretreatment with these probiotics attenuated bacterial translocation and resulted in reduced experimental mortality in AP rats.

5. Conclusions

Our results demonstrate that synbiotics containing L. casei with Inulin are effective compounds that protect the human body from oxidative stress damage. Synbiotics may have a positive influence on blood plasma antioxidant capacity and the activity of selected antioxidant enzymes, such as CAT. Therefore, the described synbiotic might be considered as a food supplement suitable for the prevention and treatment of oxidative stress injury.

Abbreviations

CAT: | Catalase
CFU: | Colony-forming unit
EDTA: | Ethylenediaminetetraacetic acid
FRAP: | Ferric reducing ability of plasma
GPx: | Glutathione peroxidase
GR: | Glutathione reductase
GSH: | Reduced glutathione
GSSG: | Glutathione disulfide
LAB: | Lactic acid bacteria
MDA: | Malondialdehyde
NADPH: | Nicotinamide adenine dinucleotide phosphate
ROS: | Reactive oxygen species
SOD: | Superoxide dismutase
TAA: | Total antioxidative activity
TAC: | Total antioxidant capacity
TAS: | Total antioxidative status
GSHt: | Total glutathione
TPTZ: | 2,3,5-Triphenyltetrazolium chloride.

Competing Interests

The authors declare no competing interests.

Acknowledgments

This study was supported by Grants nos. 503/0-149-03/503-01 and 502-03/0-149-03/502-04-029 from the Medical University of Lodz.

References

P. D. Ray, B.-W. Huang, and Y. Tsuji, “Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling,” Cellular Signalling, vol. 24, no. 5, pp. 981–990, 2012.

J. E. Klaunig, Z. Wang, X. Pu, and S. Zhou, “Oxidative stress and oxidative damage in chemical carcinogenesis,” Toxicology and Applied Pharmacology, vol. 254, no. 2, pp. 86–99, 2011.

M. Valko, C. J. Rhodes, J. Moncol, M. Izakovic, and M. Mazur, “Free radicals, metals and antioxidants in oxidative stress-induced cancer,” Chemico-Biological Interactions, vol. 160, no. 1, pp. 1–40, 2006.

P. Song and M. H. Zou, “Roles of reactive oxygen species in physiology and pathology,” in Atherosclerosis: Risks, Mechanisms, and Therapies, H. Wang and C. Patterson, Eds., pp. 379–392, John Wiley & Sons, Hoboken, NJ, USA, 2015.

K. Apel and H. Hirt, “Reactive oxygen species: metabolism, oxidative stress, and signal transduction,” Annual Review of Plant Biology, vol. 55, pp. 373–399, 2004.

T. Fukai and M. Ushio-Fukai, “Superoxide dismutases: role in redox signaling, vascular function, and diseases,” Antioxidants and Redox Signaling, vol. 15, no. 6, pp. 1583–1606, 2011.

I. N. Zelko, T. J. Mariani, and R. J. Folz, “Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression,” Free Radical Biology and Medicine, vol. 33, no. 3, pp. 337–349, 2002.

S. Chen, P. Sayana, X. Zhang, and W. Le, “Genetics of amyotrophic lateral sclerosis: an update,” Molecular Neurodegeneration, vol. 28, no. 8, pp. 1–15, 2013.

S. Miriyala, I. Spasojevic, A. Tovmasyan et al., “Manganese superoxide dismutase, MnSOD and its mimics,” Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, vol. 1822, no. 5, pp. 794–814, 2012.

C. D. Putnam, A. S. Arvai, Y. Bourne, and J. A. Tainer, “Active and inhibited human catalase structures: ligand and NADPH binding and catalytic mechanism,” Journal of Molecular Biology, vol. 296, no. 1, pp. 295–309, 2000.

P. Chelikani, I. Fita, and P. C. Loewen, “Diversity of structures and properties among catalases,” Cellular and Molecular Life Sciences, vol. 61, no. 2, pp. 192–208, 2004.

R. Francik, M. Krośniak, I. Sanocka, H. Bartoń, T. Hebda, and S. Francik, “Aronia melanocarpa treatment and antioxidant status in selected tissues in wistar rats,” BioMed Research International, vol. 2014, Article ID 457085, 9 pages, 2014.

E. Lubos, J. Loscalzo, and D. E. Handy, “Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities,” Antioxidants and Redox Signaling, vol. 15, no. 7, pp. 1957–1997, 2011.

G. R. Gibson and M. B. Roberfroid, “Dietary modulation of the human colonic microbiota. Introducing the concept of prebiotics,” Journal of Nutrition, vol. 125, no. 6, pp. 1401–1412, 1995.

B. Poljsak, “Strategies for reducing or preventing the generation of oxidative stress,” Oxidative Medicine and Cellular Longevity, vol. 2011, Article ID 194586, 15 pages, 2011.

B. M. Hybertson, B. Gao, S. K. Bose, and J. M. McCord, “Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation,” Molecular Aspects of Medicine, vol. 32, no. 4–6, pp. 234–246, 2011.

I. F. F. Benzie and J. J. Strain, “The ferric reducing ability of plasma (FRAP) as a measure of ‘antioxidant power’: the FRAP assay,” Analytical Biochemistry, vol. 239, no. 1, pp. 70–76, 1996.

https://www.caymanchem.com/pdfs/707002.pdf

https://www.caymanchem.com/pdfs/706002.pdf

https://www.caymanchem.com/pdfs/703102.pdf

D. Martarelli, M. C. Verdenelli, S. Scuri et al., “Effect of a probiotic intake on oxidant and antioxidant parameters in plasma of athletes during intense exercise training,” Current Microbiology, vol. 62, no. 6, pp. 1689–1696, 2011.

H. An, H. Zhou, Y. Huang et al., “High-level expression of heme-dependent catalase gene katA from Lactobacillus sakei protects Lactobacillus rhamnosus from oxidative stress,” Molecular Biotechnology, vol. 45, no. 2, pp. 155–160, 2010.

P. Hütt, H. Andreson, T. Kullisaar et al., “Effects of a synbiotic product on blood antioxidative activity in subjects colonized with Helicobacter pylori,” Letters in Applied Microbiology, vol. 48, no. 6, pp. 797–800, 2009.

T. Kullisaar, E. Songisepp, M. Mikelsaar, K. Zilmer, T. Vihalemm, and M. Zilmer, “Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human subjects,” British Journal of Nutrition, vol. 90, no. 2, pp. 449–456, 2003.

M. Mikelsaar and M. Zilmer, “Lactobacillus fermentum ME-3—an antimicrobial and antioxidative probiotic,” Microbial Ecology in Health and Disease, vol. 21, no. 1, pp. 1–27, 2009.

E. Songisepp, J. Kals, T. Kullisaar et al., “Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers,” Nutrition Journal, vol. 4, article 22, 2005.

M. A. Uskova and L. V. Kravchenko, “Antioxidant properties of lactic acid bacteria—probiotic and yogurt strains,” Voprosy Pitaniia, vol. 78, no. 2, pp. 18–23, 2009.

A. Amaretti, M. di Nunzio, A. Pompei, S. Raimondi, M. Rossi, and A. Bordoni, “Antioxidant properties of potentially probiotic bacteria: in vitro and in vivo activities,” Applied Microbiology and Biotechnology, vol. 97, no. 2, pp. 809–817, 2013.

A. S. Hathout, S. R. Mohamed, A. A. El-Nekeety, N. S. Hassan, S. E. Aly, and M. A. Abdel-Wahhab, “Ability of Lactobacillus casei and Lactobacillus reuteri to protect against oxidative stress in rats fed aflatoxins-contaminated diet,” Toxicon, vol. 58, no. 2, pp. 179–186, 2011.

M. Gagnon, P. Savard, A. Rivière, G. Lapointe, and D. Roy, “Bioaccessible antioxidants in milk fermented by Bifidobacterium longum subsp. longum strains,” BioMed Research International, vol. 2015, Article ID 169381, 12 pages, 2015.

Q. Shen, N. Shang, and P. Li, “In vitro and in vivo antioxidant activity of bifidobacterium animalis 01 isolated from centenarians,” Current Microbiology, vol. 62, no. 4, pp. 1097–1103, 2011.

M. Chamari, A. Djazayery, M. Jalali, H. Sadrzadeh Yeganeh, S. Hosseini, and R. Heshmat, “The effect of daily consumption of probiotic and conventional yogurt on some oxidative stress factors in plasma of young healthy women,” ARYA Atherosclerosis Journal, vol. 4, no. 4, pp. 175–179, 2008.

X. Shen, D. Yi, X. Ni et al., “Effects of lactobacillus plantarum on production performance, immune characteristics, antioxidant status, and intestinal microflora of bursin-immunized broilers,” Canadian Journal of Microbiology, vol. 60, no. 4, pp. 193–202, 2014.

H. Yadav, S. Jain, and P. R. Sinha, “Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats,” Journal of Dairy Research, vol. 75, no. 2, pp. 189–195, 2008.

S. Rajpal and V. K. Kansal, “Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum stimulates antioxidant enzyme pathways in rats,” Milchwissenschaft, vol. 64, no. 3, pp. 287–290, 2009.

T. Balog, S. Sobočanec, V. Šverko et al., “The influence of season on oxidant-antioxidant status in trained and sedentary subjects,” Life Sciences, vol. 78, no. 13, pp. 1441–1447, 2006.

J. Kodydková, L. Vávrová, M. Kocík, and A. Žák, “Human catalase, its polymorphisms regulation and changes of its activity in different diseases,” Folia Biologica, vol. 60, no. 4, pp. 153–167, 2014.

L. Rönnberg, A. Kauppila, J. Leppäluoto, H. Martikainen, and O. Vakkuri, “Circadian and seasonal variation in human preovulatory follicular fluid melatonin concentration,” Journal of Clinical Endocrinology and Metabolism, vol. 71, no. 2, pp. 493–496, 1990.

Y. Ito, T. Iida, Y. Yamamura et al., “Relationships between salivary melatonin levels, quality of sleep, and stress in young Japanese females,” International Journal of Tryptophan Research, vol. 6, supplement 1, pp. 75–85, 2013.

J. Schröder, M. Dören, B. Schneider, and M. Oettel, “Are the antioxidative effects of 17β-estradiol modified by concomitant administration of a progestin?” Maturitas, vol. 25, no. 2, pp. 133–139, 1996.

L. Góth, Lenkey A, and W. N. Bigler, “Blood catalase deficiency and diabetes in Hungary,” Diabetes Care, vol. 24, no. 10, pp. 1839–1840, 2001.

N. Niikawa, Y. Fukushima, N. Taniguchi, S. Iizuka, and T. Kajii, “Chromosome abnormalities involving 11p13 and low erythrocyte catalase activity,” Human Genetics, vol. 60, no. 4, pp. 373–375, 1982.

R. A. Omar, Y.-J. Chyan, A. C. Andorn, B. Poeggeler, N. K. Robakis, and M. A. Pappolla, “Increased expression but reduced activity of antioxidant enzymes in Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 1, no. 3, pp. 139–145, 1999.

D. Gao, Z. Gao, and G. Zhu, “Antioxidant effects of Lactobacillus plantarum via activation of transcription factor Nrf2,” Food and Function, vol. 4, no. 6, pp. 982–989, 2013.

A. N. Wang, X. W. Yi, H. F. Yu, B. Dong, and S. Y. Qiao, “Free radical scavenging activity of Lactobacillus fermentum in vitro and its antioxidative effect on growing-finishing pigs,” Journal of Applied Microbiology, vol. 107, no. 4, pp. 1140–1148, 2009.

H. S. Ejtahed, J. Mohtadi-Nia, A. Homayouni-Rad, M. Niafar, M. Asghari-Jafarabadi, and V. Mofid, “Probiotic yogurt improves antioxidant status in type 2 diabetic patients,” Nutrition, vol. 28, no. 5, pp. 539–543, 2012.

F. Gan, X. Chen, S. F. Liao et al., “Selenium-enriched probiotics improve antioxidant status, immune function, and selenoprotein gene expression of piglets raised under high ambient temperature,” Journal of Agricultural and Food Chemistry, vol. 62, no. 20, pp. 4502–4508, 2014.

S. Pandey, A. Singh, P. Kumar, A. Chaudhari, and G. Nareshkumar, “Probiotic Escherichia coli CFR 16 producing pyrroloquinoline quinone (PQQ) ameliorates 1,2-dimethylhydrazine-induced oxidative damage in colon and liver of rats,” Applied Biochemistry and Biotechnology, vol. 173, no. 3, pp. 775–786, 2014.

M. A. Ghoneim and S. S. Moselhy, “Antioxidant status and hormonal profile reflected by experimental feeding of probiotics,” Toxicology and Industrial Health, 2013.

S. Kapila, R. Kapila, S. Reddi, and P. R. Sinha, “Oral administration of probiotic Lactobacillus casei spp. casei ameliorates oxidative stress in rats,” International Journal of Current Microbiology and Applied Sciences, vol. 3, no. 9, pp. 670–684, 2014.

E. Fabian and I. Elmadfa, “The effect of daily consumption of probiotic and conventional yoghurt on oxidant and anti-oxidant parameters in plasma of young healthy women,” International Journal for Vitamin and Nutrition Research, vol. 77, no. 2, pp. 79–88, 2007.

E. Vaghef-Mehrabany, A. Homayouni-Rad, B. Alipour, S. K. Sharif, L. Vaghef-Mehrabany, and S. Alipour-Ajiry, “Effects of probiotic supplementation on oxidative stress indices in women with rheumatoid arthritis: a randomized double-blind clinical trial,” Journal of the American College of Nutrition, 2015.

M. L. Stecchini, M. Del Torre, and M. Munari, “Determination of peroxy radical-scavenging of lactic acid bacteria,” International Journal of Food Microbiology, vol. 64, no. 1-2, pp. 183–188, 2001.

R. Chauhan, A. S. Vasanthakumari, H. Panwar et al., “Amelioration of colitis in mouse model by exploring antioxidative potentials of an indigenous probiotic strain of Lactobacillus fermentum Lf1,” BioMed Research International, vol. 2014, Article ID 206732, 12 pages, 2014.

T. Cecchi, M. Savini, S. Silvi, M. C. Verdenelli, and A. Cresci, “Optimisation of the measurement of the antioxidant activity of probiotics and pathogens: a crucial step towards evidence-based assessment of health claims and production of effective functional foods,” Food Analytical Methods, vol. 8, no. 2, pp. 312–320, 2014.

Y. Ishii, S. Sugimoto, N. Izawa, T. Sone, K. Chiba, and K. Miyazaki, “Oral administration of Bifidobacterium breve attenuates UV-induced barrier perturbation and oxidative stress in hairless mice skin,” Archives of Dermatological Research, vol. 306, no. 5, pp. 467–473, 2014.

K. H. S. Farvin, C. P. Baron, N. S. Nielsen, and C. Jacobsen, “Antioxidant activity of yoghurt peptides: part 1-in vitro assays and evaluation in -3 enriched milk,” Food Chemistry, vol. 123, no. 4, pp. 1081–1089, 2010.

K. H. S. Farvin, C. P. Baron, N. S. Nielsen, J. Otte, and C. Jacobsen, “Antioxidant activity of yoghurt peptides: part 2—characterisation of peptide fractions,” Food Chemistry, vol. 123, no. 4, pp. 1090–1097, 2010.

H. Korhonen and A. Pihlanto, “Bioactive peptides: production and functionality,” International Dairy Journal, vol. 16, no. 9, pp. 945–960, 2006.

M. Hayes, C. Stanton, G. F. Fitzgerald, and R. P. Ross, “Putting microbes to work: diary fermentation, cell factories and bioactive peptides. Part II: bioactive peptide functions,” Biotechnology Journal, vol. 2, no. 4, pp. 435–449, 2007.

M.-Y. Lin and F.-J. Chang, “Antioxidative effect of intestinal bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356,” Digestive Diseases and Sciences, vol. 45, no. 8, pp. 1617–1622, 2000.

V. J. Koller, B. Marian, R. Stidl et al., “Impact of lactic acid bacteria on oxidative DNA damage in human derived colon cells,” Food and Chemical Toxicology, vol. 46, no. 4, pp. 1221–1229, 2008.

S. S. Choi, Y. Kim, K. S. Han, S. You, S. Oh, and S. H. Kim, “Effects of Lactobacillus strains on cancer cell proliferation and oxidative stress in vitro,” Letters in Applied Microbiology, vol. 42, no. 5, pp. 452–458, 2006.

D. G. Duman, Z. N. Ö. Kumral, F. Ercan, M. Deniz, G. Can, and B. Çağlayan Yeğen, “Saccharomyces boulardii ameliorates clarithromycin- and methotrexate-induced intestinal and hepatic injury in rats,” British Journal of Nutrition, vol. 110, no. 3, pp. 493–499, 2013.

T. Şahin, S. Aydin, O. Yüksel et al., “Effects of the probiotic agent Saccharomyces boulardii on the DNA damage in acute necrotizing pancreatitis induced rats,” Human and Experimental Toxicology, vol. 26, no. 8, pp. 653–661, 2007.

A. Suryavanshi, A. Agarwal, A. Kaler et al., “Comparative studies on the antioxidant potential of vanillin-producing Saccharomyces boulardii extracts,” Oxidants and Antioxidants in Medical Science, vol. 2, no. 3, pp. 201–209, 2013.

H. Annuk, J. Shchepetova, T. Kullisaar, E. Songisepp, M. Zilmer, and M. Mikelsaar, “Characterization of intestinal lactobacilli as putative probiotic candidates,” Journal of Applied Microbiology, vol. 94, no. 3, pp. 403–412, 2003.

M. Kumar, A. Kumar, R. Nagpal et al., “Cancer-preventing attributes of probiotics: an update,” International Journal of Food Sciences and Nutrition, vol. 61, no. 5, pp. 473–496, 2010.

D. Najgebauer-Lejko, “Effect of green tea supplementation on the microbiological, antioxidant, and sensory properties of probiotic milks,” Dairy Science and Technology, vol. 94, no. 4, pp. 327–339, 2014.

G. Grompone, P. Martorell, S. Llopis et al., “Anti-inflammatory Lactobacillus rhamnosus CNCM I-3690 strain protects against oxidative stress and increases lifespan in Caenorhabditis elegans,” PLoS ONE, vol. 7, no. 12, Article ID e52493, 2012.

S. Kapila, Vibha, and P. Sinha, “Antioxidative and hypocholesterolemic effect of Lactobacillus casei ssp casei (biodefensive properties of lactobacilli),” Indian Journal of Medical Sciences, vol. 60, no. 9, pp. 361–370, 2006.

B. G. Spyropoulos, E. P. Misiakos, C. Fotiadis, and C. N. Stoidis, “Antioxidant properties of probiotics and their protective effects in the pathogenesis of radiation-induced enteritis and colitis,” Digestive Diseases and Sciences, vol. 56, no. 2, pp. 285–294, 2011.

J. Lee, K.-T. Hwang, M.-Y. Chung, D.-H. Cho, and C.-S. Park, “Resistance of Lactobacillus casei KCTC 3260 to reactive oxygen species (ROS): role for a metal ion chelating effect,” Journal of Food Science, vol. 70, no. 8, pp. M388–M391, 2005.

J. Sun, X.-L. Hu, G.-W. Le, and Y.-H. Shi, “Lactobacilli prevent hydroxy radical production and inhibit Escherichia coli and Enterococcus growth in system mimicking colon fermentation,” Letters in Applied Microbiology, vol. 50, no. 3, pp. 264–269, 2010.

Y.-C. Wang, R.-C. Yu, and C.-C. Chou, “Antioxidative activities of soymilk fermented with lactic acid bacteria and bifidobacteria,” Food Microbiology, vol. 23, no. 2, pp. 128–135, 2006.

V. P. Kodali and R. Sen, “Antioxidant and free radical scavenging activities of an exopolysaccharide from a probiotic bacterium,” Biotechnology Journal, vol. 3, no. 2, pp. 245–251, 2008.

N. Şengül, B. Aslım, G. Uçar et al., “Effects of exopolysaccharide-producing probiotic strains on experimental colitis in rats,” Diseases of the Colon and Rectum, vol. 49, no. 2, pp. 250–258, 2006.

W. Han, A. Mercenier, A. Ait-Belgnaoui et al., “Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase,” Inflammatory Bowel Diseases, vol. 12, no. 11, pp. 1044–1052, 2006.

I. M. Carroll, J. M. Andrus, J. M. Bruno-Bárcena, T. R. Klaenhammer, H. M. Hassan, and D. S. Threadgill, “Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 293, no. 4, pp. G729–G738, 2007.

T. Kullisaar, M. Zilmer, M. Mikelsaar et al., “Two antioxidative lactobacilli strains as promising probiotics,” International Journal of Food Microbiology, vol. 72, no. 3, pp. 215–224, 2002.

S. K. Chang and H. M. Hassan, “Characterization of superoxide dismutase in Streptococcus thermophilus,” Applied and Environmental Microbiology, vol. 63, no. 9, pp. 3732–3735, 1997.

A. de Moreno de LeBlanc, J. G. LeBlanc, G. Perdigón et al., “Oral administration of a catalase-producing Lactococcus lactis can prevent a chemically induced colon cancer in mice,” Journal of Medical Microbiology, vol. 57, no. 1, pp. 100–105, 2008.

H. An, Z. Zhai, S. Yin, Y. Luo, B. Han, and Y. Hao, “Coexpression of the superoxide dismutase and the catalase provides remarkable oxidative stress resistance in lactobacillus rhamnosus,” Journal of Agricultural and Food Chemistry, vol. 59, no. 8, pp. 3851–3856, 2011.

L.-X. Wang, K. Liu, D.-W. Gao, and J.-K. Hao, “Protective effects of two Lactobacillus plantarum strains in hyperlipidemic mice,” World Journal of Gastroenterology, vol. 19, no. 20, pp. 3150–3156, 2013.

F. Lutgendorff, R. M. Nijmeijer, P. A. Sandström et al., “Probiotics prevent intestinal barrier dysfunction in acute pancreatitis in rats via induction of ileal mucosal glutathione biosynthesis,” PLoS ONE, vol. 4, no. 2, Article ID e4512, 2009.

L. P. van Minnen, H. M. Timmerman, F. Lutgendorff et al., “Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis,” Surgery, vol. 141, no. 4, pp. 470–480, 2007.